Skip to main content

Table 2 HPV and screening-related factors of hrHPV positive women who underwent colposcopy versus hrHPV positive non-attendees

From: Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study

 

Overall (n = 225)

Logistic regression model

 

Non-attendee (n = 49)

Attendee (n = 176)

Univariable

 

n (row %)

n (row %)

OR

95% CI

Perception

    

Negative screening experience

    

 No

9 (13.04%)

60 (86.96%)

Ref

 

 Yes

26 (22.41%)

90 (77.59%)

0.49

0.21, 1.09

 Missing

14

26

  

Level of negative reaction to HPV resulta

    

 Little to none

10 (15.87%)

53 (84.13%)

Ref

 

 Moderate to high

24 (21.82%)

86 (78.18%)

0.64

0.27, 1.41

 Missing

15

37

  

Level of understanding regarding HPV result

    

 Little to none

7 (22.58%)

24 (77.42%)

Ref

 

 Most or everything

27 (19.57%)

111 (80.43%)

1.15

0.42, 2.82

 Missing

15

41

  

Knowledge

    

HPV knowledge

    

 No

17 (18.28%)

76 (81.72%)

Ref

 

 Yes

18 (21.18%)

67 (78.82%)

0.78

0.37, 1.62

 Missing

14

33

  

Level of HPV knowledge

    

 Poor to none

5 (14.71%)

29 (85.29%)

Ref

 

 Moderate to good

13 (25.00%)

39 (75.00%)

0.64

0.20, 1.84

 Missing

31

108

  

Any HPV knowledge prior to the study

    

 No

16 (17.78%)

74 (82.22%)

Ref

 

 Yes

17 (19.32%)

71 (80.68%)

0.84

0.39, 1.78

 Missing

16

31

  

Communication

    

Of HPV result by gynaecologist

    

 No

8 (24.24%)

25 (75.76%)

Ref

 

 Yes

4 (15.38%)

22 (84.62%)

1.34

0.39, 5.03

 Missing

37

129

  

Comprehensive explanation of HPV result by gynaecologistb

    

 1 area or less

27 (20.00%)

108 (80.00%)

Ref

 

 At least 2 areas

7 (16.67%)

35 (83.33%)

1.06

0.46, 2.70

 Missing

15

33

  

Trust in gynaecologist

    

 No

3 (15.00%)

17 (85.00%)

Ref

 

 Yes

23 (19.01%)

98 (80.99%)

0.71

0.16, 2.34

 Unsure*

8 (27.59%)

21 (72.41%)

  

 Missing

15

40

  

Discussed HPV result with friend or family

    

 No

16 (26.23%)

45 (73.77%)

Ref

 

 Yes

18 (16.22%)

93 (83.78%)

1.72

0.80, 3.67

 Missing

15

38

  

Concerns

    

About cancer

    

 No

8 (18.60%)

35 (81.40%)

Ref

 

 Yes

27 (19.29%)

113 (80.71%)

0.91

0.36, 2.11

 Missing

14

28

  

About infertility

    

 No

27 (18.88%)

116 (81.12%)

Ref

 

 Yes

8 (24.24%)

25 (75.76%)

0.76

0.32, 1.96

 Missing

14

35

  

Of infecting partner

    

 No

25 (20.83%)

95 (79.17%)

Ref

 

 Yes

8 (15.38%)

44 (84.62%)

1.52

0.66, 3.84

 Missing

16

37

  

About impact on sexual intercourse

    

 No

26 (19.85%)

105 (80.15%)

Ref

 

 Yes

8 (16.67%)

40 (83.33%)

1.30

0.56, 3.27

 Missing

15

31

  
  1. OR: Odds Ratio; CI: Confidence Interval; HPV: Human Papillomavirus; hrHPV: high-risk human Papillomavirus
  2. a at least one of the following: anxiety, insecurity, nervousness, incomprehension, powerlessness
  3. b areas include: dedicated time for explaining result, background information on HPV, answered questions or concerns from patient
  4. * not included in logistic regression